MétaCan
Menu
Back to cohort
Record W3158447700 · doi:10.1016/j.cgh.2021.03.037

Prediction of Relapse After Anti–Tumor Necrosis Factor Cessation in Crohn’s Disease: Individual Participant Data Meta-analysis of 1317 Patients From 14 Studies

2021· review· en· W3158447700 on OpenAlexafffund
R Pauwels, C. Janneke van der Woude, Daan Nieboer, Ewout W. Steyerberg, María José Casanova, Javier P. Gisbert, Charlie W. Lees, Édouard Louis, Tamás Molnár, K Szántó, Eduardo Leo, Steven Bots, Robert J. Downey, Milan Lukáš, Wei Lin, Aurélien Amiot, Cathy Lu, Xavier Roblin, Klaudia Farkas, Jakob Benedict Seidelin, Marjolijn Duijvestein, Geert D’Haens, Annemarie C. de Vries, Jasmijn A M Sleutjes, José M. García-Ortiz, Alenka J Brooks, P. J. Hamlin, Shaji Sebastian, Alan Lobo, Levinus A. Dieleman, Shomron Ben‐Horin, Casper Steenholdt

Bibliographic record

VenueClinical Gastroenterology and Hepatology · 2021
Typereview
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicInflammatory Bowel Disease
Canadian institutionsUniversity of Alberta HospitalUniversity of Alberta
FundersSamsungNorgineDr. Falk PharmaTillotts PharmaOtsuka PharmaceuticalFerring PharmaceuticalsHerlev HospitalSheffield Teaching Hospitals NHS Foundation TrustAbbVieUniversity of AlbertaMylanMerckTel Aviv UniversityMeso Scale DiagnosticsTeva Pharmaceutical IndustriesCelgenePfizerBiogenJanssen PharmaceuticalsAblynxGilead SciencesCelltrionRocheGenentechHospiraAmgenVifor PharmaErasmus Universitair Medisch Centrum RotterdamShireAllerganAstraZenecaEli Lilly and CompanyTakeda Pharmaceutical Company
KeywordsMedicineMeta-analysisDiseaseInternal medicineCrohn's diseaseOncologyTumor necrosis factor alphaTumor necrosis factor α

Abstract

fetched live from OpenAlex

BACKGROUND & AIMS: Tools for stratification of relapse risk of Crohn's disease (CD) after anti-tumor necrosis factor (TNF) therapy cessation are needed. We aimed to validate a previously developed prediction model from the diSconTinuation in CrOhn's disease patients in stable Remission on combined therapy with Immunosuppressants (STORI) trial, and to develop an updated model. METHODS: Cohort studies were selected that reported on anti-TNF cessation in 30 or more CD patients in remission. Individual participant data were requested for luminal CD patients and anti-TNF treatment duration of 6 months or longer. The discriminative ability (concordance-statistic [C-statistic]) and calibration (agreement between observed and predicted risks) were explored for the STORI model. Next, an updated prognostic model was constructed, with performance assessment by cross-validation. RESULTS: This individual participant data meta-analysis included 1317 patients from 14 studies in 11 countries. Relapses after anti-TNF cessation occurred in 632 of 1317 patients after a median of 13 months. The pooled 1-year relapse rate was 38%. The STORI prediction model showed poor discriminative ability (C-statistic, 0.51). The updated model reached a moderate discriminative ability (C-statistic, 0.59), and included clinical symptoms at cessation (hazard ratio [HR], 2.2; 95% CI, 1.2-4), younger age at diagnosis (HR, 1.5 for A1 (age at diagnosis ≤16 years) vs A2 (age at diagnosis 17 - 40 years); 95% CI, 1.11-1.89), no concomitant immunosuppressants (HR, 1.4; 95% CI, 1.18-172), smoking (HR, 1.4; 95% CI, 1.15-1.67), second line anti-TNF (HR, 1.3; 95% CI, 1.01-1.69), upper gastrointestinal tract involvement (HR, 1.3 for L4 vs non-L4; 95% CI, 0.96-1.79), adalimumab (HR, 1.22 vs infliximab; 95% CI, 0.99-1.50), age at cessation (HR, 1.2 per 10 years younger; 95% CI, 1-1.33), C-reactive protein (HR, 1.04 per doubling; 95% CI, 1.00-1.08), and longer disease duration (HR, 1.07 per 5 years; 95% CI, 0.98-1.17). In subanalysis, the discriminative ability of the model improved by adding fecal calprotectin (C-statistic, 0.63). CONCLUSIONS: This updated prediction model showed a reasonable discriminative ability, exceeding the performance of a previously published model. It might be useful to guide clinical decisions on anti-TNF therapy cessation in CD patients after further validation.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.037
metaresearch head score (Gemma)0.040
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Meta-analysis · Consensus signal: Meta-analysis
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.037
Threshold uncertainty score0.194

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0370.040
Meta-epidemiology (narrow)0.0030.002
Meta-epidemiology (broad)0.0110.052
Bibliometrics0.0040.004
Science and technology studies0.0010.001
Scholarly communication0.0030.001
Open science0.0020.002
Research integrity0.0020.002
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.298
GPT teacher head0.416
Teacher spread0.117 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designMeta-analysis
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations40
Published2021
Admission routes2
Has abstractyes

Explore more

Same venueClinical Gastroenterology and HepatologySame topicInflammatory Bowel DiseaseFrench-language works237,207